UFP Technologies to Report Third Quarter 2025 Financial Results on November 3, 2025
Conference Call Scheduled for November 4th at 8:30 AM ET
NEWBURYPORT, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that the Company plans to report results for the third quarter on Monday, November 3rd, after the close of the stock market. The Company will hold a conference call to discuss the results on the following day, November 4th, at 8:30 AM Eastern time.
Conference Call Information:
Date: Tuesday, November 4, 2025
Time: 8:30 AM Eastern Time
Participants may join the call using the following dial-in numbers:
- USA/Canada: Toll-Free: 1-412-206-6478
- International: 1-833-890-4010
A live webcast of the conference call and accompanying materials will be available here.
A replay of the webcast will be accessible following the event on the Company’s Investor Relations website at https://ufpt.com/investors/.
About UFP Technologies, Inc.
UFP Technologies is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. UFP is a vital link in the medical device supply chain and a valued outsourcing partner to many of the world's top medical device manufacturers. The Company’s single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.
Investor Contact:
Jeff Elliott
Three Part Advisors, LLC
214-966-9014
UFP Technologies Contact:
Ron Lataille, CFO
978-234-0926
rlataille@ufpt.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
